Evofem Biosciences Inc. buy krebskrebs
Start price
22.03.21
/
50%
€34.73
Target price
22.03.22
€52.50
Performance (%)
-84.26%
End price
23.03.22
€5.47
Summary
This prediction ended on 23.03.22 with a price of €5.47. Massive losses of -84.26% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evofem Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by krebskrebs for this prediction
In the thread Evofem Biosciences diskutieren
In the thread Trading Evofem Biosciences
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten